Assessment of Carbon Emissions in a Study of Medical Drones Versus Standard Delivery Methods for Antiretroviral Therapy Delivery in Uganda: A Protocol
BACKGROUND: Access to antiretroviral therapy (ART) medication is essential for effective HIV management. However, ensuring reliable ART delivery to remote and underserved populations remains a major challenge in geographically isolated settings. In Kalangala District, Uganda, conventional ART transport methods such as boats, motorcycles and cars are constrained by long travel times, weather variability, poor infrastructure and dependence on fossil fuels. These barriers affect service continuity and contribute to greenhouse gas (GHG) emissions. Medical drones have emerged as a promising alternative for hard-to-reach settings, but evidence on their carbon footprint in sub-Saharan Africa (SSA) remains limited. This study therefore aims to compare the carbon footprint of drone-based ART delivery with standard delivery methods in Kalangala District over a 24-month study period. METHODS: e) per tin delivered. Emissions per delivery trip and total emissions per arm will be reported as secondary units. The study will adopt an operationally bounded system boundary applied equally to both arms, covering transport, operational energy use, packaging, health-facility utilities linked to ART delivery and waste from delivery activities. Manufacturing of vehicles, boats, drones and infrastructure construction will be excluded. Failed or aborted deliveries and replacement battery production and disposal will be examined in the sensitivity analyses. Data will be obtained from parent study operational logs, GPS tracking data, utility records and equipment specifications, with proxy data used where primary data are unavailable. Emissions will be modelled using validated emission factors databases and LCA software such as OpenLCA or SimaPro. Sensitivity analysis will be done to assess the robustness of findings under varying operational assumptions and parameters. This study was approved by the Infectious Diseases Institute Research Ethics Committee (IDI-REC-2025-203) and the Uganda National Council for Science and Technology (ref: HS6741ES), respectively. DISCUSSION: ART delivery activities in the parent study have commenced, and data collection for this study will draw on ongoing operational records. Data generated from this work will be used to quantify and compare carbon emissions associated with drone-based and standard ART delivery methods and to identify the main contributors to emissions in each arm. This study will generate context-specific evidence on the carbon footprint of drone-supported ART delivery, intended to be read alongside the parent trial's cost-effectiveness findings, so that scale-up decisions in resource-limited settings weigh environmental impact with cost and health outcomes.
Authors
- Dimitrios Pappas (ORCID: https://orcid.org/0000-0003-0325-1190)
- Agnes Bwanika Naggirinya (ORCID: https://orcid.org/0000-0001-8722-4135)
- Rosalind M. Parkes-Ratanshi (ORCID: https://orcid.org/0000-0001-9297-1311)
- Rachel Lisa King (ORCID: https://orcid.org/0000-0002-0085-3498)
- Elly Nuwamanya (ORCID: https://orcid.org/0000-0001-6979-015X)
- Patrick Ssesaazi (ORCID: https://orcid.org/0000-0002-6213-4763)
- Petra Kerubo Mariaria (ORCID: https://orcid.org/0009-0006-6322-4249)
Institutions
- Queen's University Belfast (GB)
- University of California, San Francisco (US)
- Tyndall Centre (GB)
- Makerere University (UG)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1007/s41669-026-00694-3
- Primary Topic
- Environmental Impact and Sustainability
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- UK Research and Innovation
- Medical Research Council